Mary F. Grubb

Bristol-Myers Squibb (United States)United States

Medicine · Health Sciences

11h-index438citations21works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

HIV/AIDS drug development and treatment(5), Pharmacogenetics and Drug Metabolism(4), Analytical Chemistry and Chromatography(3), Neurotransmitter Receptor Influence on Behavior(2), HIV Research and Treatment(2)

Publications21 total

ACS Medicinal Chemistry Letters·2021· 5 citedOpen Access
In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
PubMed·1997· 3 cited
Biopharmaceutics & Drug Disposition·1994· 18 cited
Drug Metabolism and Disposition·1994· 8 cited
Journal of Medicinal Chemistry·1994· 41 citedOpen Access
Serum stimulation of UDP-glucose dehydrogenase activity in Swiss 3T3 fibroblasts.
PubMed·1993· 11 cited
JNCI Journal of the National Cancer Institute·1993· 8 cited
page 1 of 2Next →

Frequent Co-authors

Christine Huang(5), Jeffrey A. Robl(4), Anthony V. Azzara(4), Mary Jane Cullen(4), Brian J. Murphy(4), Jonathan L. Josephs(3), Kimberly A. Foster(3), William N. Washburn(3), Pratik Devasthale(3), Mary Ann Pelleymounter(3), Daniel Angelo Longhi(3), Ning Huang(3), Neil Flynn(3), Kenneth W. Rohrbach(3), James J. Devenny(3), Suzanne Rooney(3), Michael A. Thomas(3), Susan Glick(3), Helen E. Godonis(3), Susan J. Harvey(3)